Drug Information

Drug General Information
Drug ID
D0OU3Q
Former ID
DIB005401
Drug Name
TAK-058
Indication Schizophrenia [ICD9: 295; ICD10:F20] Phase 1 [525122]
Target and Pathway
Target(s) 5-Hydroxytryptamine 3 receptor Target Info Antagonist [549563], [551871]
References
Ref 525122ClinicalTrials.gov (NCT02389881) Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy Participants. U.S. National Institutes of Health.
Ref 549563Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040805)
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.